The Role of Immunohistochemistry in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: An Old Tool With an Enduring Prognostic Value

Micro-Abstract Pathologic complete response (pCR) to neoadjuvant chemotherapy is a potential surrogate for survival. We defined molecular subtypes determined by hormonal receptors (HR) and human epidermal growth factor receptor 2 (HER2) status. pCR was significantly higher in patients with HR− /HER2...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical breast cancer 2013-04, Vol.13 (2), p.146-152
Hauptverfasser: Sánchez-Muñoz, Alfonso, Plata-Fernández, Yessica Maria, Fernández, Margarita, Jaén-Morago, Ana, Fernández-Navarro, Monica, de la Torre-Cabrera, Capilla, Ramirez-Tortosa, Cesar, Lomas-Garrido, Maria, Llácer, Casilda, Navarro-Perez, Victor, Alba-Conejo, Emilio, Sánchez-Rovira, Pedro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!